Tuagon, Mark Jade P.

HRN: 19-96-54  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2023
CEFUROXIME 1.5GM (VIAL)
01/16/2023
01/23/2023
IVTT
360mg
Q8
BFC; PCAP C
Waiting Final Action 
01/19/2023
CEFTRIAXONE 1G (VIAL)
01/19/2023
01/26/2023
IV
1 G
Q24
PCAP C
Waiting Final Action 
01/20/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
01/20/2023
01/24/2023
PO
2.7ml
OD
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: